Metabolic-associated Fatty Liver Disease as Assessed by the Fatty Liver Index Among Migrant and Non-migrant Ghanaian Populations
Open Access
- 8 May 2021
- journal article
- research article
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. 000 (000), 000
- https://doi.org/10.14218/jcth.2021.00066
Abstract
Metabolic-associated fatty liver disease (MAFLD) is driven by high caloric intake and sedentary lifestyle. Migration towards high income countries may induce these driving factors; yet, the influence of such on the prevalence of MAFLD is clearly understudied. Here, we investigated the Fatty Liver Index (FLI), a proxy of steatosis in MAFLD, after migration of Ghanaian subjects.Keywords
This publication has 44 references indexed in Scilit:
- 2013 ACC/AHA Guideline on the Assessment of Cardiovascular RiskJournal of the American College of Cardiology, 2014
- 2013 ACC/AHA Guideline on the Assessment of Cardiovascular RiskJournal of Invasive Cardiology, 2013
- External Validation of the Fatty Liver Index for Identifying Nonalcoholic Fatty Liver Disease in a Population-based StudyClinical Gastroenterology and Hepatology, 2013
- Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in miceJournal of Hepatology, 2013
- Intestinal microbiota determines development of non-alcoholic fatty liver disease in miceGut, 2012
- Independent Association Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease in the US PopulationClinical Gastroenterology and Hepatology, 2012
- Validation of fatty liver index and lipid accumulation product for predicting fatty liver in Korean populationLiver International, 2011
- Meta‐analysis of the influence of I148M variant of patatin‐like phospholipase domain containing 3 gene ( PNPLA3 ) on the susceptibility and histological severity of nonalcoholic fatty liver diseaseJournal of Hepatology, 2011
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver diseaseNature Genetics, 2008
- Non‐alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non‐diabetic men. Role of visceral adipose tissueDiabetic Medicine, 2005